Guanhao Biotech Co.,Ltd. (SHE:300238)
China
· Delayed Price · Currency is CNY 16.38
+0.07 (0.43%)
Jul 4, 2025, 2:45 PM CST
Guanhao Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 366.87 | 363.52 | 388.8 | 361.02 | 462.6 | 415.21 | Upgrade
|
Other Revenue | 13.97 | 13.97 | 15.38 | 16.27 | 26.38 | 21.75 | Upgrade
|
| 380.84 | 377.48 | 404.18 | 377.29 | 488.98 | 436.96 | Upgrade
| |
Revenue Growth (YoY) | -0.55% | -6.60% | 7.13% | -22.84% | 11.91% | -0.21% | Upgrade
|
Cost of Revenue | 80.52 | 78.83 | 88.26 | 159.6 | 125.38 | 125.09 | Upgrade
|
Gross Profit | 300.32 | 298.65 | 315.92 | 217.69 | 363.6 | 311.87 | Upgrade
|
Selling, General & Admin | 215.83 | 214.63 | 221.9 | 210.31 | 242.05 | 230.62 | Upgrade
|
Research & Development | 36.48 | 36.16 | 44.5 | 50.52 | 46.62 | 34.25 | Upgrade
|
Other Operating Expenses | 5.19 | 4.04 | 3.15 | 3.03 | 4.07 | 2.8 | Upgrade
|
Operating Expenses | 266.75 | 263.39 | 276.27 | 272.77 | 295.44 | 270.33 | Upgrade
|
Operating Income | 33.57 | 35.26 | 39.65 | -55.08 | 68.16 | 41.54 | Upgrade
|
Interest Expense | -1.89 | -1.03 | -1.78 | -4.11 | -7.36 | -14.58 | Upgrade
|
Interest & Investment Income | 1.33 | 1.27 | 1.5 | 2.22 | 2.19 | 3.22 | Upgrade
|
Currency Exchange Gain (Loss) | -0.12 | -0.12 | -3.52 | -2.34 | 0.58 | 1.69 | Upgrade
|
Other Non Operating Income (Expenses) | 1.48 | 0.24 | -4.11 | 1.11 | -5.8 | -2.81 | Upgrade
|
EBT Excluding Unusual Items | 34.36 | 35.62 | 31.74 | -58.2 | 57.77 | 29.07 | Upgrade
|
Impairment of Goodwill | - | - | - | -214.33 | -0.15 | - | Upgrade
|
Gain (Loss) on Sale of Investments | -10.83 | -10.84 | -3.64 | -41.36 | -4.68 | -3.14 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.92 | 0.03 | 0.33 | -0.01 | Upgrade
|
Asset Writedown | -5.27 | -4.98 | -0.29 | -3.61 | -0.05 | -0.04 | Upgrade
|
Other Unusual Items | 8.35 | 8.19 | 3.35 | 24.9 | 28.83 | 19 | Upgrade
|
Pretax Income | 26.65 | 28.02 | 32.09 | -292.58 | 82.06 | 44.88 | Upgrade
|
Income Tax Expense | 10.78 | 11.41 | 11.02 | 35.06 | 31.32 | 3.52 | Upgrade
|
Earnings From Continuing Operations | 15.86 | 16.61 | 21.07 | -327.64 | 50.74 | 41.36 | Upgrade
|
Minority Interest in Earnings | 12.03 | 10.81 | 9.93 | 19.81 | 22.95 | 5.23 | Upgrade
|
Net Income | 27.89 | 27.42 | 31.01 | -307.82 | 73.69 | 46.59 | Upgrade
|
Net Income to Common | 27.89 | 27.42 | 31.01 | -307.82 | 73.69 | 46.59 | Upgrade
|
Net Income Growth | 19.80% | -11.58% | - | - | 58.14% | - | Upgrade
|
Shares Outstanding (Basic) | 264 | 274 | 258 | 265 | 263 | 259 | Upgrade
|
Shares Outstanding (Diluted) | 264 | 274 | 258 | 265 | 263 | 259 | Upgrade
|
Shares Change (YoY) | 1.12% | 6.11% | -2.63% | 0.83% | 1.66% | -2.65% | Upgrade
|
EPS (Basic) | 0.11 | 0.10 | 0.12 | -1.16 | 0.28 | 0.18 | Upgrade
|
EPS (Diluted) | 0.11 | 0.10 | 0.12 | -1.16 | 0.28 | 0.18 | Upgrade
|
EPS Growth | 18.47% | -16.67% | - | - | 55.56% | - | Upgrade
|
Free Cash Flow | -11.86 | -26.65 | 0.23 | 29.81 | 117.68 | 100.94 | Upgrade
|
Free Cash Flow Per Share | -0.04 | -0.10 | 0.00 | 0.11 | 0.45 | 0.39 | Upgrade
|
Gross Margin | 78.86% | 79.12% | 78.16% | 57.70% | 74.36% | 71.37% | Upgrade
|
Operating Margin | 8.82% | 9.34% | 9.81% | -14.60% | 13.94% | 9.51% | Upgrade
|
Profit Margin | 7.32% | 7.26% | 7.67% | -81.59% | 15.07% | 10.66% | Upgrade
|
Free Cash Flow Margin | -3.11% | -7.06% | 0.06% | 7.90% | 24.07% | 23.10% | Upgrade
|
EBITDA | 53.62 | 55.6 | 61.16 | -31.56 | 94.51 | 69.72 | Upgrade
|
EBITDA Margin | 14.08% | 14.73% | 15.13% | -8.37% | 19.33% | 15.96% | Upgrade
|
D&A For EBITDA | 20.05 | 20.34 | 21.51 | 23.52 | 26.35 | 28.18 | Upgrade
|
EBIT | 33.57 | 35.26 | 39.65 | -55.08 | 68.16 | 41.54 | Upgrade
|
EBIT Margin | 8.82% | 9.34% | 9.81% | -14.60% | 13.94% | 9.51% | Upgrade
|
Effective Tax Rate | 40.48% | 40.73% | 34.33% | - | 38.17% | 7.83% | Upgrade
|
Revenue as Reported | 380.84 | 377.48 | 404.18 | 377.29 | 488.98 | 436.96 | Upgrade
|
Advertising Expenses | - | 10.97 | 12.39 | 9.43 | 15.72 | 8.6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.